Abnormal expression of the angiopoietins and Tie receptors in menorrhagic endometrium

Fertility and Sterility

Volumn 78, Issue 6, 2002, Pages 1294-1300

  Blumenthal, Rosalyn D ^a   Taylor, Alice P ^a   Goldman, Lisa ^a   Brown, Gloria ^a   Goldenberg, David M ^a  

^a GARDEN STATE CANCER CENTER   (United States)

Author keywords

Angiopoietin; Endometrium; Menorrhagia; Nitric oxide; Tie 2

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; NITRIC OXIDE SYNTHASE; TIE 1 RECEPTOR; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL SPECIFICITY; CLINICAL ARTICLE; CONTROLLED STUDY; CURETTAGE; ENDOMETRIUM; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MENOPAUSE; MENORRHAGIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR DISEASE; VASCULARIZATION;

ANGIOGENESIS INDUCING AGENTS; ANGIOPOIETIN-1; ANGIOPOIETIN-2; ENDOMETRIUM; FEMALE; FOLLICULAR PHASE; HUMANS; IMMUNOHISTOCHEMISTRY; LUTEAL PHASE; MEMBRANE GLYCOPROTEINS; MENORRHAGIA; NEOPLASM PROTEINS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; POSTMENOPAUSE; PREMENOPAUSE; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, TIE-1; RECEPTOR, TIE-2; RECEPTORS, CELL SURFACE; RECEPTORS, TIE; RETROSPECTIVE STUDIES;

EID: 0036905356     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(02)04276-0     Document Type: Article

References (35)

1. Anderson J., Shaw H. Menorrhagia. eMed J. 2:2001;. topic 1449.
2. Bulletti C., Flamigni C., Prefetto R.A., Polli V., Giacomucci E. Dysfunctional uterine bleeding (DUB). Ann N Y Acad Sci. 734:1994;80-90.
3. Bayer S., DeCherney A. Clinical manifestations and treatment of dysfunctional uterine bleeding. JAMA. 269:1993;1823-1828.
4. Sheppard B. The pathology of dysfunctional uterine bleeding. Clin Obstet Gynecol. 11:1984;227-236.
5. Apgar B.S. Dysmenorrhea and dysfunctional uterine bleeding. Prim Care. 24:1997;161-178.
6. Galle P.C. Clinical presentation and diagnosis of endometriosis. Obstet Gynecol Clin North Am. 16:1989;29-42.
7. Meyer W.R., Walsh B.W., Grainger D.A., Peacock L.M., Loffer F.D., Steege J.F. Thermal balloon and rollerball ablation to treat menorrhagia a multicenter comparison . Obstet Gynecol. 92:1998;98-103.
8. Rosenfeld J.A. Treatment of menorrhagia due to dysfunctional uterine bleeding. Am Fam Physician. 53:1996;165-172.
9. Peek M.J., Markham R., Fraser I.S. Angiogenic activity in normal and dysfunctional uterine bleeding human endometrium; as measured by the chick chorioallantoic membrane assay. Exp Toxic Pathol. 47:1995;397-402.
10. Goodger A., Rogers P. Endometrial endothelial cell proliferation during the menstrual cycle. Hum Reprod. 9:1994;399-405.
11. Iruela-Arispe M., Porter P., Bornstein P., Sage E. Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium. J Clin Invest. 97:1996;403-412.
12. Giudice L. Growth factors and growth modulators in human uterine endometrium their potential relevance to reproductive medicine . Fertil Steril. 61:1994;1-17.
13. Kooy J., Taylor N.H., Healy D.L., Rogers P.A. Endothelial cell proliferation in the endometrium of women with menorrhagia and in women following endometrial ablation. Hum Reprod. 11:1996;1067-1072.
14. Goodger A., Rogers P. Blood vessel growth in the endometrium. Microcirculation. 2:1995;329-343.
15. Jenkins D., Charles I., Baylis S., Lelchuk R., Radomski M. Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br J Cancer. 70:1994;847-849.
16. Lauren J., Gunji y, Alitalo K. Is angiopoietin-2 necessary for the initiation of tumor angiogenesis? Am J Pathol. 153:1998;1333-1339.
17. Sato T., Tozawa Y., Deutsch U., Wolburg-Buchholz K., Fujiwara Y., Gendron-Maguire M., et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature. 376:1995;70-74.
18. Puri M.C., Rossant J., Alitalo K., Bernstein A., Partanen J. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. Embo J. 14:1995;5884-5891.
19. Wong A., Haroon Z., Werner S., Dewhirst M., Greenberg C., Peters K. Ties2 expression and phosphorylation in angiogenic and quiescent adult tissue. Cancer Res. 81:1997;567-574.
20. Witzenbichler B., Maisonpierre P., Jones P., Yancopoulos G., Isner J. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem. 273:1998;18514-18521.
21. Koblizek T., Weiss C., Yancopoulos G., Deutsch U., Risau W., Suri C., et al. Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr Biol. 8:1998;529-532.
22. Papapetropoulos A., Garcia-Cardhena G., Dengler T., Maisonpierre P., Yancopoulos G., Sessa W. Direct actions of angiopoietin-1 on human endothelium evidence for network stabilization, cell survival and interaction with other angiogenic growth factors . Lab Invest. 79:1999;213-233.
23. Patan S. TIE1 and TIE2 receptor tyrosine kinases inversely regulate embryonic angiogenesis by the mechanism of intussusceptive microvascular growth. Microvasc Res. 56:1998;1-21.
24. Maisonpierre P.C., Suri C., Jones P.F., Bartunkova S., Wiegand S.J., Radziejewski C., et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 277:1997;55-60.
25. Peters K. Vascular endothelial growth factor and the angiopoietins working together to build a better blood vessel . Circ Res. 83:1998;342-343.
26. Asahara T., Chen D., Takahashi T., Fujikawa K., Kearney M., Magner M., et al. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. [see comments] Circ Res. 83:1998;233-240.
27. Rodewald H., Sato T. Tie1, a receptor tyrosine kinase essential for the vascular endothelial cell integrity, is not critical for the development of hematopoietic cells. Oncogene. 12:1996;397-404.
28. Boughton-Smith N.K., Evans S.M., Laszlo F., Whittle B.J., Moncada S. The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br J Pharmacol. 110:1993;1189-1195.
29. Maeda H., Noguchi Y., Sato K., Akaike T. Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor. Jpn J Cancer Res. 85:1994;331-334.
30. Mayhan W. Role of nitric oxide in modulating permeability of hamster cheek pouch in response to adenosine 5′diphosphate and bradykinin. Inflammation. 16:1992;295-305.
31. Oucevic A., Lalc P. NG-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis ameliorates interleukin-2 induced capillary lack syndrome in healthy mice. J Immunother. 18:1996;210-220.
32. Marsh M., Malakooti N., Taylor N., Findlay J., Salamonsen L. Endothelin and neutral endopeptidase in the endometrium of women with menorrhagia. Hum Reprod. 12:1997;2036-2040.
33. Salamonsen L., Marsh M., Findlay J. Endometrial endothelin regulator of uterine bleeding and endometrial repair . Clin Exp Pharmacol Physiol. 26:1999;154-157.
34. Sangha R., Li X., Shams M., Ahmed A. Fibroblast growth factor receptor-1 is a critical component for endometrial remodeling localization and expression of basic fibroblast growth factor, and FGF-R in human endometrium during the menstrual cycle and decreased FGF-R1 expression in menorrhagia . Lab Invest. 77:1997;389-402.
35. Kothapalli R., Buyuksal I., Wu S., Chgini N., Tabibzadeh S. Detection of ebaf, a novel human gene of the transforming growth factor beta superfamily association of gene expression with endometrial bleeding. J Clin Invest. 99:1997;2342-2350.